WoundClot™ Hemostatic Gauze is an FDA cleared, next generation hemostatic gauze engineered to be effective in the management of mild, moderate, and severe bleeding. WoundClot™ is also effective in the temporary management of severe bleeding during surgical procedures as well as postoperative and donor-site bleeding.
When WoundClot™ Trauma gauze is applied to the site of bleeding, it rapidly converts from a dry fexible gauze to a thick, tenacious, expanding 3D gel matrix. This stable, strong, and pliant gel structure enables rapid and stable hemostasis to be achieved utilizing several mechanisms of action:
WoundClot™ Trauma absorbs up to 2,500% of its weight in blood and remains actively absorbent for up to 24 hours.
WoundClot™’s 3D gel matrix enables the concentration of platelets, red blood cells, and clotting factors, creating an environment conducive to clotting.
WoundClot™’s pliant 3D gel matrix adheres to surrounding tissues in the wound and will not be dislodged by patient movement, wound manipulation, or high-pressure bleeding.
“WoundClot™’s advanced functional molecular groups stimulate the coagulation process by converting Plasma Thromboplastin Antecedent or PTA (XI) and Hageman (XII) clotting factors from inactive to active (XIa and XIIa).” To WoundClot™’s advanced functional molecular groups stimulate the coagulation process, enabling rapid and stable hemostasis to be achieved.
Effective in patients on anticoagulant/antiplatelet therapy.
Effective in patients in Coagulopathy.
Does not require the application of manual pressure to be effective.
A high safety profile and has no contraindications.
Can be used anywhere on the body.
Available in a variety of sizes and conforms and adheres to any anatomical shape effectively.
Zero toxicity – no harmful side effects or residues.
Does not stick to gloves or instruments.
Simple to use and requires minimal training to be utilised effectively.
WoundClot™ is made from cellulose, a natural fiber product. WoundClot™ is the only NonOxidized, Non-Regenerated Cellulose Structure (NONRCS) product in world. Other hemostatics made from cellulose are manufactured utilizing a obsolete method that breaks down cellulose by oxidization, greatly decreasing the product’s ability to absorb blood, adhere to wound surfaces, and create an environment that is conducive to achieving hemostasis.
WoundClot™ is made from cellulose, a natural fiber product. WoundClot™ is the only NonOxidized, Non-Regenerated Cellulose Structure (NONRCS) product in world. Due to its unique patented manufacturing process, WoundClot™ does not require a “active Ingredient”. The material itself is engineered to be inherently hemostatic. Other hemostatics are made using a synthetic or natural substrate impregnated with an active ingredient like, Kaolin, Chitosan, Collagen, Silica, or Thrombin.
Mineral based hemostatics are comprised of a non-resorbable, non-woven fiber impregnated with an active ingredient like Kaolin. Kaolin is an inorganic fine, white clay powder, resulting from the natural decomposition of other clays or feldspar. These products work utilizing a single mechanism of action: activation of Factor XII (Hagman Factor). They require the application of intense manual pressure for at least 3-5 minutes in order to be effective. WoundClot™ utilizes multiple mechanisms of action: Rapid fluid absorption, adherence and expansion in the wound, aggregation of platelets, RBCs, and clotting factors, creating an environment conducive to clotting, as well activation of Factors XI and XII. WoundClot™ also is actively absorbent for up to 24 hours in the wound
Chitosan based hemostatics are comprised of a non-resorbable, non-woven fiber impregnated with the active ingredient, Chitosan. Chitosan is a sugar that is obtained from the hard-outer skeleton of shellfish, including crab, lobster, and shrimp. These products utilize a single mechanism of action: attracting negatively charged Red Blood Cells (RBCs) with its positively charged active ingredient. WoundClot™ utilizes multiple mechanisms of action: Rapid fluid absorption, adherence and expansion in the wound, aggregation of platelets, RBCs, and clotting factors, creating an environment conducive to clotting, as well as activation of 2 key clotting factors. WoundClot™ also is actively absorbent for up to 24 hours in the wound.
ORC hemostatics are based on more than 75+ year-old technology. These products have a tendency to stick to gloved hands and instruments, not the intended wound surfaces. Some ORCs are FDA Class III surgical Implantable products, but their Instructions for use indicate they shouldbe removed whenever possible due to the increased risk of infection or adverse reaction. ORCs are not designed to be used if persistent or heavy bleeding is occurring. WoundClot™ is the world’s only NONRCS and is highly absorbent (up to 2,500% of its weight in fluid), highly adherent to
wound surfaces—even in high pressure bleeding—and is actively absorbent for up to 24 hours in the wound. WoundClot™ is specifically engineered to effectively manage mild, moderate, and severe bleeding.
Unlike any other hemostatic product available today, WoundClot™ has multiple mechanisms of action. When WoundClot™’s patented non-oxidized regenerated cellulosic structure contacts blood, it converts into a thick, tenacious, expanding gel, adhering to wound surfaces. WoundClot™ does not require the application of manual pressure to be effective. WoundClot™ is highly absorbent and will absorb up to 2,500% its weight in fluid. It also remains actively absorbent for up to 24 hours. Additionally, Core Scientific has engineered specific functional molecular groups into WoundClot™ that will activate 2 key clotting factors. WoundClot™ has a high safety profile and can be used anywhere on the body and requires little to no training to utilize effectively.
Yes, it is one of the mechanisms of action WoundClot™ utilizes to achieve rapid hemostasis. WoundClot™ is engineered with specific functional molecular groups that activate Factors XI and XII.
WoundClot™ is a FDA cleared, hemostatic that is indicated for the effective control of mild, moderate and severe bleeding, as well as bleeding in operative, post-operative and donor sites. It is cleared to be in a wound for up to 24 hours and must be removed prior to closure. WoundClot™ is also a CE Class III Surgical Implantable device in the EU and other places around the world, for sizes up to 4”x4”.
WoundClot™ is easily removed from wound by simply removing the clot. Rebleeding will not occur and any remaining gel can be easily irrigated out of the wound.
Currently, the shelf life is 5 years.
WoundClot™ is effective in patients on antiplatelet/anticoagulant therapy. This is due to WoundClot™’s multiple mechanisms of action.
Yes, the product is EXCELLENT for bleeding noses. Also, great for bloody lips.